Document Detail


Ertapenem-induced acute pancreatitis in a surgical elderly patient.
MedLine Citation:
PMID:  18046618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Case summary A 78-year old man was given, after surgery, 1 g ertapenem every 24 h intravenously. His clinical evolution was favorable and on day 8 ertapenem was discontinued and the patient was put on a semi-solid diet. On day 9, abdominal distension was seen accompanied by epigastric pain. The laboratory tests on day 8 showed an altered pancreatic profile: amylase = 1823 U/l (normal value: 0-100); lipase = 8045 U/l (normal value: 0-60); C-reactive protein (CRP) = 16.09 mg/dl (normal value: 0-0.5). Full Blood Count (FBC) showed leukocytosis with an increase in neutrophils and eosinophils. The prior pancreatic parameters were normal without leukocytosis. The evolution of clinical symptoms after discontinuing ertapenem was rapid. Between days 11 and 16, the laboratory parameters returned to normal values; the eosinophilia persisted longer, decreasing between days 14 and 16. Conclusions clinicians should include monitoring the development of acute pancreatitis in the safety parameters in patients undergoing treatment with this carbapenem.
Authors:
Francisco Martínez-Granados; José Noé Navarro; José Luis Estrada; María Teresa Martínez-Lazcano; Félix Lluis-Casajuana; Juan Pablo Ordovás-Baines
Related Documents :
23651038 - Self-expanding plastic stent removed after radiochemotherapy for advanced esophageal ca...
12464868 - Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the ...
17457158 - Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, dou...
23306948 - Impact of the use of plasma rich in growth factors (prgf) on the quality of life of pat...
22662298 - Intra-articular patterns of bucket handle meniscal tears and its relation to reducibility.
23723268 - Outcomes and complications of total hip replacement in super-obese patients.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2007-11-28
Journal Detail:
Title:  Pharmacy world & science : PWS     Volume:  30     ISSN:  0928-1231     ISO Abbreviation:  Pharm World Sci     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-04-17     Completed Date:  2008-10-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307352     Medline TA:  Pharm World Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  278-80     Citation Subset:  IM    
Affiliation:
Pharmacy Service, Hospital General Universitario de Alicante, C/ Maestro Alonso, Alicante, Spain. fmartinezgranados@redfarma.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Amylases / analysis
Anti-Bacterial Agents / adverse effects*
Blood Cell Count
Enteral Nutrition
Eosinophils
Humans
Leukocyte Count
Lipase / blood
Male
Pancreatic Function Tests
Pancreatitis / chemically induced*,  diet therapy
beta-Lactams / adverse effects*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/beta-Lactams; 0/ertapenem; EC 3.1.1.3/Lipase; EC 3.2.1.-/Amylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Locating air quality monitoring station using wind impact area diagram.
Next Document:  Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling ...